Funded Tech Companies

ImmunoMet

Operating out of Houston, ImmunoMet has funding from Mirae Asset Venture Investment, NHN Investment and private investors.

Company Overview

Contact Information

Company Background Information

Overview

ImmunoMet Therapeutics is a development-stage biotechnology company, focused on the development of innovative oncology products to improve the quality of life and make a meaningful difference in the lives of cancer patients.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/8/2017

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Benjamin Cowen

        

Chief Financial Officer

Michael Bell

        

Chief Medical Officer

Marc Rudoltz

        

Vice President

Sanghee Yoo

        

VP - Operations

Steve Pondell

        

VP - R & D

Dean Welsch

        

Company Investors

• Mirae Asset Venture Investment (Jae Kim)
• NHN Investment
• Private Investors (Sung-wuk Kum)

Browse more funded tech companies:

Immunome | Immunomic Therapeutics

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary